Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.businesswire.com/news/home/20230822179307/en/Exavir-Therapeutics-Receives-3M-Award-from-NIH-NIAID-to-Advance-Ultra-Long-Acting-Integrase-Inhibitor-XVIR-110
Research Institution
Exavir Therapeutics
Short Title
Exavir Therapeutics Receives $3 Million Award from NIH / NIAID to Advance Ultra-Long-Acting Integrase Inhibitor XVIR-110
Content Coordinator